Labcorp Holdings EPS History: Annual & Quarterly (LH)
Labcorp Holdings's diluted EPS was $10.46 for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual diluted eps history
| Fiscal year | Period ended | Diluted EPS | Basic EPS | Change | Growth |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $10.46 | $10.54 | $1.62 | +18.33% |
| 2024 | 2024-12-31 | $8.84 | $8.89 | $4.07 | +85.32% |
| 2023 | 2023-12-31 | $4.77 | $4.80 | -$9.20 | −65.86% |
| 2022 | 2022-12-31 | $13.97 | $14.05 | -$10.42 | −42.72% |
| 2021 | 2021-12-31 | $24.39 | $24.60 | $8.51 | +53.59% |
| 2020 | 2020-12-31 | $15.88 | $15.99 | $7.53 | +90.18% |
| 2019 | 2019-12-31 | $8.35 | $8.42 | -$0.26 | −3.02% |
| 2018 | 2018-12-31 | $8.61 | $8.71 | -$3.20 | −27.10% |
| 2017 | 2017-12-31 | $11.81 | $11.99 | $4.99 | +73.17% |
| 2016 | 2016-12-31 | $6.82 | $6.94 | $2.47 | +56.78% |
| 2015 | 2015-12-31 | $4.35 | $4.43 | -$1.56 | −26.40% |
| 2014 | 2014-12-31 | $5.91 | $6.03 | -$0.34 | −5.44% |
| 2013 | 2013-12-31 | $6.25 | $6.36 | $0.26 | +4.34% |
| 2012 | 2012-12-31 | $5.99 | $6.09 | $0.88 | +17.22% |
| 2011 | 2011-12-31 | $5.11 | $5.20 | -$0.18 | −3.40% |
| 2010 | 2010-12-31 | $5.29 | $5.42 | $0.31 | +6.22% |
| 2009 | 2009-12-31 | $4.98 | $5.06 | $0.82 | +19.71% |
| 2008 | 2008-12-31 | $4.16 | $4.23 | $0.23 | +5.85% |
| 2007 | 2007-12-31 | $3.93 | $4.08 | — | — |
Labcorp Holdings quarterly diluted eps
| Fiscal quarter | Period ended | Diluted EPS | Basic EPS | Change | YoY change |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.64 | $3.66 | $0.80 | +28.17% |
| Q1 2026 | 2026-03-31 | $3.35 | $3.37 | $0.83 | +32.94% |
| Q4 2025 | 2025-12-31 | $1.98 | $2.00 | — | — |
| Q3 2025 | 2025-09-30 | $3.12 | $3.14 | $1.12 | +56.00% |
| Q2 2025 | 2025-06-30 | $2.84 | $2.85 | $0.41 | +16.87% |
| Q1 2025 | 2025-03-31 | $2.52 | $2.54 | -$0.17 | −6.32% |
| Q3 2024 | 2024-09-30 | $2.00 | $2.02 | -$0.11 | −5.21% |
| Q2 2024 | 2024-06-30 | $2.43 | $2.44 | $0.31 | +14.62% |
| Q1 2024 | 2024-03-31 | $2.69 | $2.71 | $0.30 | +12.55% |
| Q3 2023 | 2023-09-30 | $2.11 | $2.12 | -$1.79 | −45.90% |
| Q2 2023 | 2023-06-30 | $2.12 | $2.13 | -$1.75 | −45.22% |
| Q1 2023 | 2023-03-31 | $2.39 | $2.41 | -$2.84 | −54.30% |
| Q3 2022 | 2022-09-30 | $3.90 | $3.91 | -$2.15 | −35.54% |
| Q2 2022 | 2022-06-30 | $3.87 | $3.89 | -$0.89 | −18.70% |
| Q1 2022 | 2022-03-31 | $5.23 | $5.27 | -$2.59 | −33.12% |
| Q3 2021 | 2021-09-30 | $6.05 | $6.10 | -$1.12 | −15.62% |
| Q2 2021 | 2021-06-30 | $4.76 | $4.80 | $2.39 | +100.84% |
| Q1 2021 | 2021-03-31 | $7.82 | $7.88 | $11.09 | — |
| Q3 2020 | 2020-09-30 | $7.17 | $7.22 | $4.92 | +218.67% |
| Q2 2020 | 2020-06-30 | $2.37 | $2.38 | $0.44 | +22.80% |
| Q1 2020 | 2020-03-31 | -$3.27 | -$3.27 | -$5.13 | — |
| Q4 2019 | 2019-12-31 | $2.32 | $2.34 | $0.76 | +48.72% |
| Q3 2019 | 2019-09-30 | $2.25 | $2.26 | -$0.85 | −27.42% |
| Q2 2019 | 2019-06-30 | $1.93 | $1.94 | -$0.34 | −14.98% |
| Q1 2019 | 2019-03-31 | $1.86 | $1.88 | $0.19 | +11.38% |
| Q4 2018 | 2018-12-31 | $1.56 | $1.58 | -$5.07 | −76.47% |
| Q3 2018 | 2018-09-30 | $3.10 | $3.14 | $1.45 | +87.88% |
| Q2 2018 | 2018-06-30 | $2.27 | $2.29 | $0.49 | +27.53% |
| Q1 2018 | 2018-03-31 | $1.67 | $1.70 | -$0.08 | −4.57% |
| Q4 2017 | 2017-12-31 | $6.63 | $6.73 | $4.88 | +278.86% |
| Q3 2017 | 2017-09-30 | $1.65 | $1.68 | -$0.06 | −3.51% |
| Q2 2017 | 2017-06-30 | $1.78 | $1.80 | -$0.18 | −9.18% |
| Q1 2017 | 2017-03-31 | $1.75 | $1.79 | $0.17 | +10.76% |
| Q4 2016 | 2016-12-31 | $1.75 | $1.79 | $0.68 | +63.55% |
| Q3 2016 | 2016-09-30 | $1.71 | $1.74 | $0.20 | +13.25% |
| Q2 2016 | 2016-06-30 | $1.96 | $2.00 | $0.30 | +18.07% |
| Q1 2016 | 2016-03-31 | $1.58 | $1.61 | $1.54 | +3850.00% |
| Q4 2015 | 2015-12-31 | $1.07 | $1.09 | -$0.30 | −21.90% |
| Q3 2015 | 2015-09-30 | $1.51 | $1.53 | -$0.08 | −5.03% |
| Q2 2015 | 2015-06-30 | $1.66 | $1.69 | $0.02 | +1.22% |
| Q1 2015 | 2015-03-31 | $0.04 | $0.04 | -$5.87 | −99.32% |
| Q4 2014 | 2014-12-31 | $1.37 | $1.41 | -$0.06 | −4.20% |
| Q3 2014 | 2014-09-30 | $1.59 | $1.62 | -$0.04 | −2.45% |
| Q2 2014 | 2014-06-30 | $1.64 | $1.67 | $0.02 | +1.23% |
| Q1 2014 | 2014-03-31 | $5.91 | $6.03 | $4.35 | +278.85% |
| Q4 2013 | 2013-12-31 | $1.43 | $1.46 | $0.17 | +13.49% |
| Q3 2013 | 2013-09-30 | $1.63 | $1.66 | $0.10 | +6.54% |
| Q2 2013 | 2013-06-30 | $1.62 | $1.65 | $0.06 | +3.85% |
| Q1 2013 | 2013-03-31 | $1.56 | $1.58 | -$0.07 | −4.29% |
| Q4 2012 | 2012-12-31 | $1.26 | $1.28 | -$0.08 | −5.97% |
| Q3 2012 | 2012-09-30 | $1.53 | $1.56 | $0.22 | +16.79% |
| Q2 2012 | 2012-06-30 | $1.56 | $1.59 | $0.36 | +30.00% |
| Q1 2012 | 2012-03-31 | $1.63 | $1.66 | $0.40 | +32.52% |
| Q4 2011 | 2011-12-31 | $1.34 | $1.36 | $0.08 | +6.35% |
| Q3 2011 | 2011-09-30 | $1.31 | $1.34 | -$0.03 | −2.24% |
| Q2 2011 | 2011-06-30 | $1.20 | $1.22 | -$0.26 | −17.81% |
| Q1 2011 | 2011-03-31 | $1.23 | $1.27 | -$0.02 | −1.60% |
| Q4 2010 | 2010-12-31 | $1.26 | $1.29 | -$0.07 | −5.26% |
| Q3 2010 | 2010-09-30 | $1.34 | $1.37 | $0.13 | +10.74% |
| Q2 2010 | 2010-06-30 | $1.46 | $1.48 | $0.22 | +17.74% |
| Q1 2010 | 2010-03-31 | $1.25 | $1.27 | $0.03 | +2.46% |
| Q4 2009 | 2009-12-31 | $1.33 | $1.35 | — | — |
| Q3 2009 | 2009-09-30 | $1.21 | $1.22 | $0.21 | +21.00% |
| Q2 2009 | 2009-06-30 | $1.24 | $1.26 | $0.32 | +34.78% |
| Q1 2009 | 2009-03-31 | $1.22 | $1.23 | — | — |
| Q3 2008 | 2008-09-30 | $1.00 | $1.02 | — | — |
| Q2 2008 | 2008-06-30 | $0.92 | $0.94 | — | — |
Labcorp Holdings diluted eps trends
Over the last five fiscal years, Labcorp Holdings's diluted eps decreased from $15.88 to $10.46, a change of -$5.42. The latest reported quarter, Q2 2026, shows $3.64.
What earnings per share (EPS) means
Earnings per share (EPS) shows how much profit or loss is attributable to each common share. Diluted EPS includes the potential effect of convertible securities, options, and other instruments that could increase the share count, while basic EPS uses the weighted-average common shares actually outstanding.
SEC-reported diluted and basic EPS
TickerStat displays diluted and basic earnings per share from SEC filings. Historical EPS values are adjusted to the current share basis when SEC-reported stock-split conversion ratios are available; they are not analyst estimates or earnings forecasts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...